Akèy › Kondisyon po › Kalifòni
Etid klinik pou Kondisyon po nan Kalifòni
11 etid pou Kondisyon po ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Amicis Research Center Valencia, Northridge
- Children'S Hospital of Orange County, Orange
- Clinical Trials Research Institute, Thousand Oaks
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049575A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
- Dermatology Research Associates, Los Angeles
- University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego
- ak 2 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT05723198A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- ak 4 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
- Stanford University School of Medicine, Dermatology Department, Palo Alto
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07027345A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- Center for Dermatology Clinical Research, Inc, Fremont
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Apr 22, 2026 · NCT07144852Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
- Center for Dermatology Clinical Research, Inc, Fremont
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Apr 22, 2026 · NCT07144345Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- Beckman Laser Institute and Medical Clinic, Irvine
- Dermatology Clinic at Gavin Herbert Eye Institute, Irvine
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 16 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT00842283Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2022 · NCT04684602Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.